NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE115359 Query DataSets for GSE115359
Status Public on Jun 06, 2018
Title Gene expression changes in HEI-193 (NF2-deficient Schwannoma) cells by NF2-restoring or TEW7197 treatment.
Organism Homo sapiens
Experiment type Expression profiling by array
Summary Neurofibromatosis type 2 (NF2) syndrome is a very rare human genetic disease and until now, it’s proper treatment has not been suggested. In our recent study, it has been reported that the loss of NF2 activates MAPK signaling through reduction of RKIP in a mesothelioma model. Here, we show that loss of NF2 induces reduction of the TGF-β receptor 2 (TβR2) expression and an overwhelming expression of TGF-β receptor 1 is activated by physical stimuli such as pressure or heavy materials. Activated TR1 induced the phosphorylation and degradation of RKIP. RKIP reduction consequently results in MAPK activation as well as Snail-mediated p53 suppression and occurrence of EMT in NF2-deficient cells by physical stimuli. Thus, TβR1 kinase inhibitors restore cell differentiation and induce growth suppression in NF2 deficient Schwannoma cell line and MEF. Moreover, TEW7197, a specific TβR1 kinase inhibitor, reduces tumor formation in the NF2-model mouse (Postn-Cre;NF2f/f). Gene expression profiling reveals that TEW7197-treatment induces the expression of lipid metabolism-related gene set such as NF2-restored cells in HEI-193 (NF2-deficient Schwannoma). Our results indicate that reduction or deletion of TβR2 or NF2 induces the TβR1-mediated oncogenic pathway, and therefore inhibition of the unbalanced TGF-β signaling is a putative strategy for NF2-related cancers (NF2 syndrome and mesothelioma) and TβR2 mutated advanced cancers.
To know the global effect of TEW7197, we performed the microarray with HEI-193.
 
Overall design For differential gene expression analysis by NF2 transfection and TEW7197 treatment, microarray was performed using the Affymetrix GeneChip (Human Gene 2.0 ST Array; DNA Link, Inc, Korea). Total RNA obtained from HEI-193 transfected with NF2 (about 60% transfection yield) or treated with TEW7197 (10 M for 12 hr or 24 hr) was quantified and used for analysis. For differentially expressed gene (DEG) analysis, probes were selected if the difference in expressions were 1.5 fold compared to the HEI-193 control, and were statistically filtered by t-test (p<0.05). For the functional analysis, only DEG probes were used. Web tool DAVID (david.abcc.ncifcrf.gov/home.jsp), data base of which are Gene Ontology, KEGG, BIOCARTA and OMIM_DISEAE, was used for functional grouping of probes. All statistical and functional analysis were performed by DNA Link, Inc.
 
Contributor(s) Cho J, Oh A, Park S, Kang S, Yoon M, Woo T, Park B
Citation(s) 30135214
Submission date Jun 05, 2018
Last update date Mar 15, 2019
Contact name Bum-Joon Park
E-mail(s) bjpark1219@pusan.ac.kr
Phone 82-51-510-2220
Organization name Pusan National University
Department Molecular Biology
Lab Lab of Cancer Research
Street address Busandaehak-ro 63
City BUSAN
ZIP/Postal code 609-735
Country South Korea
 
Platforms (1)
GPL16686 [HuGene-2_0-st] Affymetrix Human Gene 2.0 ST Array [transcript (gene) version]
Samples (4)
GSM3176530 Hei193-Control
GSM3176531 Hei193-NF2
GSM3176532 Hei193-TEW10uM-12hr
Relations
BioProject PRJNA474687

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE115359_1._DEG.xlsx 14.1 Mb (ftp)(http) XLSX
GSE115359_2._DEG.xlsx 14.0 Mb (ftp)(http) XLSX
GSE115359_3._DEG.xlsx 14.0 Mb (ftp)(http) XLSX
GSE115359_RAW.tar 30.4 Mb (http)(custom) TAR (of CEL)
Processed data included within Sample table
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap